Close
Close
Treatment Database
lenalidomide
Trade Name Revlimid
Orphan Indication Mantle cell lymphoma
USA Market Approval 05-06-2013
USA Designation Date 27-04-2009
Sponsor Celgene Corporation
86 Morris Avenue
Summit, New Jersey, 07901
More about Mantle cell lymphoma
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
9,312 views
by Abidemi Uruejoma
9,814 views
by Abidemi Uruejoma
10,410 views